University of Michigan's Rogel Cancer Center: Study Provides An Explanation And Potential Solution For Severe Graft-Versus-Host Disease
February 03, 2023
February 03, 2023
ANN ARBOR, Michigan, Feb. 3 (TNSjou) -- The University of Michigan's Rogel Cancer Center issued the following news release on Feb. 2, 2023:
The severity of immune-mediated intestinal diseases such as graft-versus-host disease (GVHD) or inflammatory bowel diseases is known to be associated with alterations in the gut microbiome, but what leads to such disruption in the microbial community has remained a mystery.
Researchers at Baylor College of Medicine, the Univers . . .
The severity of immune-mediated intestinal diseases such as graft-versus-host disease (GVHD) or inflammatory bowel diseases is known to be associated with alterations in the gut microbiome, but what leads to such disruption in the microbial community has remained a mystery.
Researchers at Baylor College of Medicine, the Univers . . .